Trazenta Randomized study for USing insulin patient of Type 2 Diabetes
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2019
At a glance
- Drugs Linagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms TRUST2
- 04 Mar 2019 Status changed from active, no longer recruiting to completed.
- 30 May 2016 Status changed from recruiting to active, no longer recruiting.
- 11 Jun 2013 New trial record